spacer
home > pmps > spring 2019 > making your mark
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Making Your Mark

Unique device identification (UDI) is a system used to identify medical devices entering the healthcare supply chain. Each device (and version or model thereof) will have a designated number assigned by the manufacturer or labeller which must be added in both machine- (Auto ID) and human-readable form to both the packaging and, in some cases, the device itself, provided doing so is required under the regulation. The rule also necessitates dates on medical device labels to conform to a standard format: day-month-year (eg, 30-09-2013) to ensure dates are unambiguous and clearly understood by device users. Standards have been developed by regulators, such as the FDA, to increase patient safety via the ability to effectively track devices through their distribution and use. In Europe, the European Commission has introduced the European Medical Devices Directive to ensure the health and safety of EU citizens is protected in this area (1).

As a globally recognised standard, every medical device manufacturer will be required to comply with the regulations, which state that a UDI must be included on device labels and packages, unless an exception or alternative is stated within the rules.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Thierry Protas is the Global Pharma Director at Videojet Technologies. He leads a dedicated global pharma team who support organisations and supply chain partners with coding solutions, certifications, and fast, reliable service. Thierry has spent the last 30 years in the pharma industry within different organisations. He started in the automation business where he used to work with the major pharma original equipment manufacturers, before moving to the coding industry as a CO2 laser expert, with pharma end-users being his key focus. Thierry then moved to brand protection to focus on pharma customers, providing them with multiple solutions to fight counterfeiting.
spacer
Thierry Protas
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Huge CPhI & P-MEC China a direct result of surging manufacturing

Shanghai, 22 July, 2019:CPhI and P-MEC China – organized by China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE), Informa Markets, and Shanghai Sinoexpo Informa Markets – saw record numbers of attendees as the pharma market in China continues to grow. The three-day Shanghai event featured 3,200+ exhibiting companies, spanning the entire pharma supply chain, and provides a strong indication of the market’s overall growth patterns and future development.
More info >>

White Papers

Clinical Trials in Ukraine: Orange Paper Overview and 1st Half Year 2014

Synergy Research Group

The Orange Paper is an analytical report about the clinical trials market in Russia, published quarterly by the contract research organization Synergy Research Group. The first edition of Orange Paper was released in 2006, and at the moment 31 issues have already published. Now, thanks to Synergy Group Ukraine, obtaining information about the market of clinical trials in Ukraine has become possible. In Ukraine, during the period from 1996 to 2013, applicants had obtained 3,864 positive conclusions about the possibility of conducting clinical trials of drugs, both for domestic and foreign manufacturers, including conduct of multinational multi-center clinical trials (hereinafter – MMCTs)
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement